These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 9727320

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [The treatment of patients with benign prostatic hyperplasia with Proscar MSD (finasteride)].
    Stepanov VN, Teodorovich OV, Seregin AV, Kadyrov ZA.
    Urol Nefrol (Mosk); 1995; (5):28-30. PubMed ID: 8571480
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [The long-term treatment of patients with benign prostatic hyperplasia using Proscar].
    Lopatkin NA, Roilans PJ, Stoner E.
    Urol Nefrol (Mosk); 1996; (1):2-4. PubMed ID: 8659035
    [Abstract] [Full Text] [Related]

  • 5. [Proscar (finasteride, MSD) in the treatment of patients with prostatic hyperplasia].
    Pytel' IuA, Vinarov AZ.
    Urol Nefrol (Mosk); 1996; (4):25-7. PubMed ID: 8928344
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Treatment of benign prostatic hyperplasia with Proscar (finasteride). Results of a 10-year Scandinavian study].
    Tveter KJ, Beisland HO, Andersen JT, Wolf H, Ekman P, Johansson JE, Kontturi M, Lehtonen T.
    Tidsskr Nor Laegeforen; 1996 Nov 10; 116(27):3226-30. PubMed ID: 9011975
    [Abstract] [Full Text] [Related]

  • 8. 5alpha-reductase inhibitors/finasteride.
    Stoner E.
    Prostate Suppl; 1996 Nov 10; 6():82-7. PubMed ID: 8630236
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Comparative evaluation of the effectiveness and safety of combined drug therapy of patients with benign prostatic hyperplasia with finasteride and alfuzozine].
    Loran OB, Pushkar' DIu, Rasner PI.
    Urologiia; 2002 Nov 10; (1):19-22. PubMed ID: 11877966
    [Abstract] [Full Text] [Related]

  • 12. Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasia.
    Roehrborn CG, Bruskewitz R, Nickel JC, McConnell JD, Saltzman B, Gittelman MC, Malek GH, Gottesman JE, Suryawanshi S, Drisko J, Meehan A, Waldstreicher J, Proscar Long-Term Efficacy and Safety Study Group.
    J Urol; 2004 Mar 10; 171(3):1194-8. PubMed ID: 14767299
    [Abstract] [Full Text] [Related]

  • 13. Finasteride in the treatment of benign prostatic hyperplasia.
    Ekman P, Andersen JT, Wolf H.
    Acta Urol Belg; 1996 Mar 10; 64(1):IX-XII. PubMed ID: 8659328
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of terazosin and finasteride in symptomatic benign prostatic hyperplasia: A comparative study.
    Anwarul Islam AK, Kashem MA, Shameem IA, Kibria SA.
    Bangladesh Med Res Counc Bull; 2005 Aug 10; 31(2):54-61. PubMed ID: 16967810
    [Abstract] [Full Text] [Related]

  • 15. Maintenance of clinical efficacy with finasteride therapy for 24 months in patients with benign prostatic hyperplasia. The Finasteride Study Group.
    Stoner E.
    Arch Intern Med; 1994 Jan 10; 154(1):83-8. PubMed ID: 7505563
    [Abstract] [Full Text] [Related]

  • 16. Early diagnosis of prostate cancer in finasteride treated BPH patients.
    Tarle M, Kraus O, Trnski D, Reljic A, Ruzic B, Katusic J, Spajic B, Kusic Z.
    Anticancer Res; 2003 Jan 10; 23(1B):693-6. PubMed ID: 12680169
    [Abstract] [Full Text] [Related]

  • 17. Drug treatment for benign prostatic hyperplasia. To interpret PSA concentrations in patients taking finasteride, multiply them by two.
    Taneja S.
    BMJ; 1997 Aug 09; 315(7104):371. PubMed ID: 9270475
    [No Abstract] [Full Text] [Related]

  • 18. Effect of long-term administration of finasteride (MK-906), an inhibitor of 5 alpha-reductase, in patients with benign prostatic hyperplasia.
    Yoshida O, Oishi K, Okada Y, Mizutani Y, Itokawa Y, Tomoyoshi T, Okada K, Komatz Y, Matsuda T, Takeuchi H.
    Hinyokika Kiyo; 1996 Apr 09; 42(4):323-31. PubMed ID: 8693970
    [Abstract] [Full Text] [Related]

  • 19. [Finasteride preoperative preparation of patients with prostatic adenoma to transurethral prostatic resection].
    Tkachuk VN, Al'-Shukri SKh, Tkachuk IN.
    Urologiia; 2008 Apr 09; (1):27, 29, 31. PubMed ID: 18652018
    [Abstract] [Full Text] [Related]

  • 20. An economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia.
    McDonald H, Hux M, Brisson M, Bernard L, Nickel JC.
    Can J Urol; 2004 Aug 09; 11(4):2327-40. PubMed ID: 15380054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.